Stat reported that Lilly and the FDA allowed a 79-year-old man to gain access to the retatrutide through the FDA’s compassionate use program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results